DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Protein, Amino Acids & Insulin & Glucagon Secretion in Humans

Information source: Minneapolis Veterans Affairs Medical Center
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Type 2 Diabetes; Metabolic Syndrome

Intervention: water, glucose with or without amino acid (Other)

Phase: N/A

Status: Recruiting

Sponsored by: Minneapolis Veterans Affairs Medical Center

Official(s) and/or principal investigator(s):
Frank Q Nuttall, M.D., Ph.D., Principal Investigator, Affiliation: Minneapolis VA Health Care System

Overall contact:
Frank Q Nuttall, M.D., Ph.D., Phone: 612-467-4424, Email: nutta001@umn.edu

Summary

The purpose of this study is to determine the effect of various foods and/or food substances such as fats or proteins on the blood glucose and insulin concentrations in people with and without type 2 diabetes.

Clinical Details

Official title: The Effect of Ingestion of Foods on the Plasma Glucose and Insulin Response in Subjects With Type 2 Diabetes: Protein, Amino Acids & Insulin & Glucagon Secretion in Humans

Study design: Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject)

Primary outcome: Change in blood glucose concentration

Secondary outcome: Change in serum insulin concentration

Detailed description: Various foods or food substances are given as a test meal. The metabolic response is determined at various times after the administration of the meal (e. g. blood glucose, and other hormones and metabolites).

Eligibility

Minimum age: 18 Years. Maximum age: 80 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Subjects with or without type 2 diabetes

- C-Peptide > 1. 5 ng/ml

- Able to come to the Minneapolis VA Medical Center on several occasions over 2-4 weeks

Exclusion Criteria:

- Body mass index > 40

- hematologic abnormalities

- liver disease

- kidney disease

- congestive heart failure

- life threatening malignancies

Locations and Contacts

Frank Q Nuttall, M.D., Ph.D., Phone: 612-467-4424, Email: nutta001@umn.edu

Minneapolis VA Health Care System, Minneapolis, Minnesota 55417, United States; Recruiting
Frank Q Nuttall, M.D., Ph.D., Phone: 612-467-4424, Email: nutta001@umn.edu
Mary C. Gannon, Ph.D., Phone: 612/467-2895, Email: ganno004@umn.edu
Frank Q Nuttall, M.D, Ph.D., Principal Investigator
Additional Information

Starting date: August 1982
Last updated: November 18, 2011

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017